EcoDrugPlus

Ensembl ID : ENSCSEG00000008496
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSCSEG00000007364
Gene Symbol: -
Cross references: -
199 Possible Orthologues:

Ensembl ID : ENSCSEG00000007370
Gene Symbol: -
Cross references: -
193 Possible Orthologues:

Ensembl ID : ENSCSEG00000019694
Gene Symbol: -
Cross references: -
138 Possible Orthologues:

Ensembl ID : ENSCSEG00000002462
Gene Symbol: -
Cross references: -
164 Possible Orthologues:

Ensembl ID : ENSCSEG00000002295
Gene Symbol: -
Cross references: -
225 Possible Orthologues:

Ensembl ID : ENSCSEG00000013811
Gene Symbol: -
Cross references: -
207 Possible Orthologues:

Ensembl ID : ENSCSEG00000016273
Gene Symbol: -
Cross references: -
146 Possible Orthologues:

Ensembl ID : ENSCSEG00000000790
Gene Symbol: -
Cross references: -
339 Possible Orthologues:

Ensembl ID : ENSCSEG00000019196
Gene Symbol: -
Cross references: -
152 Possible Orthologues:

Ensembl ID : ENSCSEG00000004080
Gene Symbol: -
Cross references: -
193 Possible Orthologues:

Ensembl ID : ENSCSEG00000020811
Gene Symbol: -
Cross references: -
195 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).